Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension-Reference-Cited by-同舟云学术

Prolonged release oxycodone–naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extension

Published:2013-12 Issue:12 Volume:12 Page:1141-1150
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Trenkwalder Claudia,Beneš Heike,Grote Ludger,García-Borreguero Diego,Högl Birgit,Hopp Michael,Bosse Björn,Oksche Alexander,Reimer Karen,Winkelmann Juliane,Allen Richard P,Kohnen Ralf

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference55 articles.

1. European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Sciences, the European Neurological Society and the European Sleep Research Society;García-Borreguero;Eur J Neurol,2012

2. Augmentation as a treatment complication of restless legs syndrome: concept and management;García-Borreguero;Mov Disord,2007

3. The treatment of restless legs syndrome and periodic limb movement disorder in adults—an update for 2012: practice parameters with an evidence-based systematic review and meta-analyses;Aurora;Sleep,2012

4. Algorithms for the diagnosis and treatment of restless legs syndrome in primary care;García-Borreguero;BMC Neurol,2011

5. Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo;Walters;Sleep,1993

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term intrathecal infusion of low-dose morphine effectively relieves symptoms of severe restless legs syndrome/Willis–Ekbom disease without inducing opioid tolerance;Pain;2024-08-06

2. Medication refractory restless legs syndrome: Real-world experience;Journal of the Neurological Sciences;2024-08

3. Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome;Expert Review of Neurotherapeutics;2024-07-31

4. Restless-Legs-Syndrom;Neurologie up2date;2024-06

5. Restless legs syndrome, neuroleptic-induced akathisia, and the iron opioid dopamine link;SLEEP;2024-01-08